Inflammatory disorders

Nearly 5 million asthmatics could benefit from antifungal therapy

An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from The University of Manchester and the University of Toronto.

Genetics

Genetic mutation linked with typical form of migraine

A research team led by a Howard Hughes Medical Institute investigator at the University of California, San Francisco has identified a genetic mutation that is strongly associated with a typical form of migraine.

Inflammatory disorders

Trial asthma drug targets lung inflammation

University of Adelaide researchers at the Royal Adelaide Hospital are involved in the world's biggest study of its kind investigating a possible new treatment for asthma.

Alzheimer's disease & dementia

Technology cuts the cost of dementia care

Due to its ageing population, the Netherlands is seeing an explosive growth in the number of dementia patients. This is expected to increase from 250,000 in 2013 to 500,000 in 2050. Cost cutting in the healthcare sector, ...

Diseases, Conditions, Syndromes

Europe-wide pollen count map unveiled

In future there could be precise, personal travel warnings for hay fever sufferers covering the whole of Europe. The pollen warning service of the MedUni Vienna is working on a pollen count map in order to be better able ...

page 19 from 24